Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 12:27 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 73–96 of 164 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Chronic Neuropathic Pain Clear all

Conditions: Corneal Pain, Chronic Pain, Neuropathic Pain
Interventions: Transcranial Direct Current Stimulation (tDCS); Device
Lead sponsor: Spaulding Rehabilitation Hospital; Other
Eligibility: 18 Years to 65 Years
Enrollment: 26 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2012 – 2015
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Chronic Neuropathic Pain
Interventions: ORAVESCENT Fentanyl Citrate; Drug
Lead sponsor: Cephalon; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 2005
U.S. locations: 17
States / cities: Jonesboro, Arkansas • Bakersfield, California • San Diego, California + 13 more

Conditions: Chronic Pain, Failed Back Surgery Syndrome, Complex Regional Pain Syndromes, Neuropathic Pain
Interventions: Spinal cord stimulation; Device
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years and older
Enrollment: 34 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Pain
Interventions: flecainide acetate; Drug
Lead sponsor: Eastern Cooperative Oncology Group; Network
Eligibility: 19 Years to 120 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: Started 1998
U.S. locations: 6
States / cities: Cedar Rapids, Iowa • Des Moines, Iowa • Kalamazoo, Michigan + 3 more

Conditions: Peripheral Nerve Stimulation, Chronic Neuropathic Pain, Chronic Neuropathic Pain (Below the Shoulders)
Interventions: Peripheral Nerve Stimulation, Conventional Care Regimen; Device · Procedure
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older
Enrollment: 148 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 2
States / cities: Palo Alto, California • Kansas City, Kansas

Conditions: Trigeminal Neuropathic Pain
Interventions: Transcranial ExAblate, Sham Transcranial ExAblate, Crossover Transcranial Exablate; Device
Lead sponsor: InSightec; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2023
U.S. locations: 1
States / cities: Charlottesville, Virginia

Conditions: Neuropathic Pain, Spinal Cord Injury
Interventions: Modified-release morphine, Placebo; Drug
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 18 Years to 65 Years
Enrollment: 17 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2013
U.S. locations: 1
States / cities: New York, New York

Conditions: Chronic Pain, Neuropathic Pain, Failed Back Surgery Syndrome, Complex Regional Pain Syndromes
Interventions: HD Study Electrode; Device
Lead sponsor: Albany Medical College; Other
Eligibility: 18 Years to 90 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2023
U.S. locations: 1
States / cities: Albany, New York

Conditions: Neuropathic Pain, Postherpetic Neuralgia
Interventions: PFM-guided cortical stimulation; Device
Lead sponsor: University of Minnesota; Other
Eligibility: 22 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2027 – 2030
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Chronic Neuropathic Pain, Chronic Pain Management, Spinal Cord Stimulation (SCS), Pain Modulation, Failed Back Surgery Syndrome
Interventions: Spinal Cord Stimulation - In Clinic, Spinal Cord Stimulation - Neurosphere; Device
Lead sponsor: Mahesh Pattabiraman; Industry
Eligibility: 19 Years and older
Enrollment: 32 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Grand Island, Nebraska

Conditions: Spinal Cord Injuries, Neuralgia, Chronic Pain
Interventions: Transcranial Magnetic Stimulation; Device
Lead sponsor: Icahn School of Medicine at Mount Sinai; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023
U.S. locations: 1
States / cities: New York, New York

Conditions: Burning Mouth Syndrome
Interventions: Not listed
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 55 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2008
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Chronic Pain, Pain, Neuropathic, Neuropathic Pain
Interventions: Spinal Cord Stimulator; Device
Lead sponsor: Ashwin Viswanathan; Other
Eligibility: 22 Years and older
Enrollment: 43 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Symptomatic Neuroma, Morton's Neuroma, Chronic Nerve Pain
Interventions: AxoGuard® Nerve Cap, Standard Neurectomy; Device · Procedure
Lead sponsor: Axogen Corporation; Industry
Eligibility: 18 Years and older
Enrollment: 86 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2023
U.S. locations: 11
States / cities: Los Angeles, California • Saint Augustine, Florida • Roswell, Georgia + 8 more

Conditions: Neuropathic Pain, Chronic Pain
Interventions: neuromodulation; Device
Lead sponsor: University of Virginia; Other
Eligibility: 18 Years to 80 Years
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2028
U.S. locations: 1
States / cities: Charlottesville, Virginia

Conditions: Pain, Chronic Pain, Neuropathic Pain
Interventions: Evoke; Device
Lead sponsor: WVU Medicine Thomas Hospitals; Other
Eligibility: 18 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: Charleston, West Virginia

Conditions: Chronic Pain, Intractable Pain, Low Back Pain, Pain, Neuropathic, Pain, Back
Interventions: Spinal Cord Stimulation; Device
Lead sponsor: Boston Scientific Corporation; Industry
Eligibility: 18 Years and older
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Greenville, South Carolina

Conditions: Sequelae of; Infection, Post Infection Glomerulonephritis, Post-Infectious Peripheral Neuralgia, Post-Infectious Disorder (Disorder), Post-Infectious Arthritis, Post-Infectious Polyneuritis, Post-Infectious Parkinsonism, Post-Infectious Hypothyroidism, Post Infectious Osteoarthritis, Anxiety Disorders, Depression, Depression, Anxiety, Depression, Bipolar, Insomnia, GERD, Gastro Esophageal Reflux, Hepatitis, Glomerulonephritis
Interventions: PurWet, FurFat, PurApo, PurPhl, PurClo, PurInf, Smoliv; Combination Product
Lead sponsor: All Natural Medicine Clinic, LLC; Other
Eligibility: Not listed
Enrollment: 2,000 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Rockville, Maryland

Conditions: Healthy, Hyperalgesia, Pain, Peripheral Nervous System Disease
Interventions: Oxygen-15 Water, Capsaicin; Drug
Lead sponsor: National Institute of Dental and Craniofacial Research (NIDCR); NIH
Eligibility: Not listed
Enrollment: 273 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 1992 – 2005
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Complex Regional Pain Syndrome Type I, Complex Regional Pain Syndrome Type II
Interventions: Placebo, Neurotropin; Drug
Lead sponsor: National Institute of Nursing Research (NINR); NIH
Eligibility: 18 Years and older
Enrollment: 21 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2000 – 2012
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Chronic Peripheral Neuropathy Pain in Diabetics
Interventions: Bicifadine; Drug
Lead sponsor: XTL Biopharmaceuticals; Industry
Eligibility: 18 Years to 90 Years
Enrollment: 250 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2008
U.S. locations: 1
States / cities: Paducah, Kentucky

Conditions: Brachial Plexus Injury
Interventions: Ketamine Infustion; Drug
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Migraine
Interventions: Botulinum toxin type A; Drug
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years to 65 Years
Enrollment: 37 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2023
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Sciatica, Lumbar Radiculopathy, Lower Back Pain, Degenerative Disc Disease, Chronic Low-back Pain (cLBP), Chronic Low Back and Leg Pain, Back Pain
Interventions: Active Cannabis, Placebo Cannabis; Drug
Lead sponsor: University of California, San Diego; Other
Eligibility: 21 Years to 65 Years
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2027
U.S. locations: 1
States / cities: La Jolla, California

Search by objective public record fields.

Effects of Transcranial Direct Current Stimulation (tDCS) in Chronic Corneal Pain

Study to Evaluate the Efficacy and Safety of ORAVESCENT Fentanyl Citrate for the Management of Breakthrough Pain

Sensory Testing of Multiple Forms of Spinal Cord Stimulation for Pain

Flecainide in Treating Patients With Chronic Neuropathic Pain

Mechanisms of Stimulation for Pain Alleviation

Feasibility Study of ExAblate Thalamotomy for Treatment of Chronic Trigeminal Neuropathic Pain

Effectiveness of Controlled-Release Morphine for Chronic Neuropathic Pain After Spinal Cord Injury

Intraoperative Neuromonitoring Recording With a Novel SCS Paddle: Phase II

Simultaneous Engagement of Networks for Alleviating Pain (SENAP)

Exploring Neurosphere's Remote Monitoring and Virtual Clinic Features in Improve Quality of Life and Reduce Costs

Long-term Effects of Repetitive TMS in Chronic Neuropathic Pain in People With SCI

A Study of the Association of Sleep Dysfunction and Burning Mouth Syndrome

Novel Stimulation Patterns to Improve the Effectiveness of Spinal Cord Stimulation

Study of AxoGuard® Nerve Cap and Neurectomy for Treatment of Symptomatic Neuroma & Prevention of Recurrent Neuroma Pain

Insula Neuromodulation for Chronic Neuropathic Pain

Real-World Efficacy of Evoke® Closed-loop Spinal Cord Stimulation (CL-SCS) Therapy in Chronic Pain Patients (ULTRA).

Study to Evaluate Automated Intensity Management in Patients Undergoing a BSC SCS Temporary Trial

Recovering Damaged Cells for Sequelae Caused by COVID-19, SARS-CoV-2

Positron Emission Tomography to Measure Pain and Pain Control

Neurotropin to Treat Chronic Neuropathic Pain

A 52-Week Study of Bicifadine in Patients With Chronic Neuropathic Pain Associated With Diabetic Peripheral Neuropathy

Ketamine Infusion for Neuropathic Pain in Brachial Plexus Injuries

(Botox) Mechanisms of Action in Altering the Molecular Environment in Which Pain Fibers Exist

Brain Mechanisms Supporting Cannabis-induced Pain Relief